← Leaderboards
Terrence S. Furey
Univ Of North Carolina Chapel Hill
$2,641,182
Attributed
$6,009,153
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,009,153 · 5
By mechanism
R01$6,009,153 · 5
Top collaborators
- Shehzad Z. Sheikh10 shared
- Gregory E Crawford3 shared
- Ivan Rusyn3 shared
- Yoav Gilad1 shared
- Jason D Lieb1 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Scott T Magness$8,849,731
- Wei Sun$8,390,591
- James Stephen Marron$1,233,408
- John A Staley$413,295
Others in their field
Top investigators on “Chromatin”
- Michael P Snyder · Yale University$98,050,605
- Bing Ren · Ludwig Institute For Cancer Research$76,818,585
- John A Stamatoyannopoulos · Regulome Corporation$56,022,526
- Bradley E Bernstein · Brigham And Women'S Hospital$44,846,223
- Eric J Nestler · Icahn School Of Medicine At Mount Sinai$42,440,927
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$40,714,772
Research focus
ChromatinAffectGeneticGenesLinkTissuesVariantGenetic TranscriptionGene ExpressionGenotypePathogenesisCellsInflammatory Bowel DiseasesIntestinesS DiseaseTissue SampleGenome Wide Association StudyMolecularQuantitative Trait LociRegulationColonCrohn&AposPublic Health RelevanceRegulatory Element
Grant awards (13)
High throughput functional studies of IBD-associated GWAS variants$655,744
R01 · FY2025 · DK
Multi-omic characterization of genetic variants in IBD risk loci$459,943
R01 · FY2025 · DK · contact PI
High throughput functional studies of IBD-associated GWAS variants$637,105
R01 · FY2024 · DK
Multi-omic characterization of genetic variants in IBD risk loci$459,943
R01 · FY2024 · DK · contact PI
High throughput functional studies of IBD-associated GWAS variants$671,329
R01 · FY2023 · DK
Integrative Genetic and Genomic Analyses in the Inflammatory Bowel Disease$303,192
R01 · FY2018 · DK
Integrative Genetic and Genomic Analyses in the Inflammatory Bowel Disease$303,192
R01 · FY2017 · DK
Genes, genomes, and genotoxicity: in vivo epigenetic toxicology of 1,3-butadiene$546,211
R01 · FY2016 · ES · contact PI
Integrative Genetic and Genomic Analyses in the Inflammatory Bowel Disease$294,750
R01 · FY2016 · DK
Genes, genomes, and genotoxicity: in vivo epigenetic toxicology of 1,3-butadiene$547,025
R01 · FY2015 · ES · contact PI
Interpreting molecular role of DNA variants associated with Crohn's Disease through integrative analysis of open chromatin, epigenome and transcriptome data in diverse and relevant tissues and cells$288,103
R01 · FY2015 · ES · contact PI
Genes, genomes, and genotoxicity: in vivo epigenetic toxicology of 1,3-butadiene$542,413
R01 · FY2014 · ES · contact PI
Interpreting molecular role of DNA variants associated with Crohn's Disease through integrative analysis of open chromatin, epigenome and transcriptome data in diverse and relevant tissues and cells$300,203
R01 · FY2014 · ES · contact PI